|
Volumn 36, Issue 5, 2001, Pages 447-460
|
Stereospecific synthesis and biological evaluations of β-L-pentofuranonucleoside derivatives of 5-fluorouracil and 5-fluorocytosine
|
Author keywords
L nucleoside analogues; 5 Fluorocytosine; 5 Fluorouracil; Anti HBV activity; Anti HIV activity; Anti tumoral activity
|
Indexed keywords
1 (2 DEOXY BETA LEVO ERYTHRO PENTOFURANOSYL) 5 FLUOROCYTOSIN;
1 (2 DEOXY BETA LEVO ERYTHRO PENTOFURANOSYL) 5 FLUOROURACIL;
1 (2 DEOXY BETA LEVO THREO PENTOFURANOSYL) 5 FLUOROCYTOSINE;
1 (2 DEOXY BETA LEVO THREO PENTOFURANOSYL) 5 FLUOROURACIL;
1 (BETA LEVO ARABINOFURANOSYL) 5 FLUOROCYTOSINE;
1 (BETA LEVO ARABINOFURANOSYL) 5 FLUOROURACIL;
1 (BETA LEVO RIBOFURANOSYL) 5 FLUOROCYTOSINE;
1 (BETA LEVO RIBOFURANOSYL) 5 FLUOROURACIL;
1 (BETA LEVO XYLOFURANOSYL) 5 FLUOROCYTOSINE;
1 (BETA LEXO XYLOFURANOSYL) 5 FLUOROURACIL;
2' DEOXY BETA DEXTRO RIBOFURANONUCLEOSIDE 5 FLUORORACIL;
ANTIINFECTIVE AGENT;
ANTIVIRUS AGENT;
BETA LEVO PENTOFURANONUCLEOSIDE DERIVATIVE;
FLUCYTOSINE;
FLUCYTOSINE DERIVATIVE;
FLUOROURACIL DERIVATIVE;
NUCLEOSIDE DERIVATIVE;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL MODEL;
ANTIVIRAL ACTIVITY;
ARTICLE;
BREAST CARCINOMA;
CANCER INHIBITION;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG SCREENING;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HEPATITIS;
HUMAN;
HUMAN CELL;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LEUKEMIA;
MOUSE;
NONHUMAN;
REACTION ANALYSIS;
STEREOSPECIFICITY;
T LYMPHOCYTE;
TUMOR CELL;
ANIMALS;
ANTI-HIV AGENTS;
ANTINEOPLASTIC AGENTS;
CELL DIVISION;
DRUG DESIGN;
FLUCYTOSINE;
FLUOROURACIL;
HIV;
HUMANS;
MICE;
NUCLEOSIDES;
STEREOISOMERISM;
STRUCTURE-ACTIVITY RELATIONSHIP;
T-LYMPHOCYTES;
TUMOR CELLS, CULTURED;
|
EID: 0035328957
PISSN: 02235234
EISSN: None
Source Type: Journal
DOI: 10.1016/S0223-5234(01)01238-7 Document Type: Article |
Times cited : (15)
|
References (40)
|